Safety, Tolerability, and Pharmacokinetics of KBP-5074 Following Oral Administration in Chronic Kidney Disease
Clinical trial NCT02837237 · COMPLETED
Trial details
- NCT number
- NCT02837237
- Sponsor
- KBP Biosciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-13
- Primary completion
- 2016-12-20
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.